DTx Pharma's Option/Warrant Round

DTx Pharma raised a round of funding on August 30, 2017.

DTx Pharma is developing a technology that enables delivery of double-stranded oligonucleotide therapeutics to multiple cell types and tissues.…

Articles about DTx Pharma's Option/Warrant Round: